Trial Profile
A Phase 1, Open-label, 2-period Fixed-sequence Study to Evaluate the Effect of Multiple Doses of SHP620 (Maribavir) on the Pharmacokinetics of Digoxin and Dextromethorphan in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Maribavir (Primary) ; Dextromethorphan; Digoxin
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- Sponsors Shire
- 06 Aug 2019 Results assessing the effects of multiple oral doses of maribavir on CYP2D6 and P-gp activity in healthy adults by assessing the plasma, PK profile of the probe drugs published in the Journal of Clinical Pharmacology
- 20 Sep 2016 Status changed from recruiting to completed.
- 24 Aug 2016 Status changed from not yet recruiting to recruiting.